Article
MicroRNA-149 rs2292832 C/T Polymorphism Predicts the Prognosis of Hepatocellular Carcinoma Patients With Bone Metastasis.
Laboratory medicine - 3 Nov 2022
Feng Jian, Liu Zhen, Yu Long, Wu Chaoyu, Luo Xiao-Bo
Abstract excerpt
OBJECTIVE: The prognostic markers of hepatocellular carcinoma (HCC) patients with bone metastasis are of great significance for the design of treatment strategy, the maintenance of life quality of the patients, and the improvement of cancer prognosis. MicroRNA-149 (miR-149) rs2292832 C/T polymorphism in HCC patients has been reported to be associated with the risk of HCC, but whether it can predict the prognosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
